Navigation Links
Improved Pharma to teach at upcoming Sustainable Medicines in Africa Program
Date:8/29/2019

Prof. Stephen R. Byrn travels to Africa several times a year to teach in the Sustainable Medicines in Africa program, which includes a master’s degree in biotechnology innovation and regulatory science. The next course will take place in Arusha, Tanzania September 2nd through 13th, 2019. Topics to be addressed include Manufacturing, Quality, Regulation, Devices, Harmonization, Innovation, Drug Development, Legal, Control, Lab, Statistics, Audits, Inspections, and INDs.

About 12 years ago, shortly after selling SSCI, Byrn was contacted by Sister Zita Ekeocha of the Medical Missionaries of Mary in Africa. She was teaching industrial pharmacy at the Kilimanjaro School of Pharmacy (KSP) in Moshi, Tanzania, and she was looking for a way to expand the program for her students. Byrn and his wife Sally decided to take some of the funds from the sale of SSCI and used it to help establish the program, working with Purdue University and the KSP. The goal of the program is to enable the manufacture of quality medicines in Africa by Africans. Since its inception, the program has graduated over 100 students and has now expanded to the MS-TCDC, ActionAid Denmark in Arusha, Tanzania, with the support of a grant from the Bill and Melinda Gates Foundation. Some of the profits from Improved Pharma are also used to help support the program in Africa.

For more information on our work in Africa, please visit this link.

Stephen R. Byrn, Ph.D., FAAPS, is the Charles B. Jordan Professor of Medicinal Chemistry for the Department of Industrial and Physical Pharmacy and co-director of the Biotechnology Innovation and Regulatory Science Center at Purdue University. He is also the founder of two pharmaceutical research and information companies, SSCI West Lafayette and Improved Pharma LLC. He currently serves as the Chief Scientific Officer for Improved Pharma, a research and information company dedicated to improving pharmaceutical methods, formulations, and processes. Current research is focused on using synchrotron X-ray powder diffraction to understand the structure of amorphous materials.    

About Improved Pharma
For more information about the techniques discussed in this article or about Improved Pharma’s services, please contact us at 1-765-463-9951 or info@improvedpharma.com.

Read the full story at https://www.prweb.com/releases/improved_pharma_to_teach_at_upcoming_sustainable_medicines_in_africa_program/prweb16530427.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. KBioBox Offers Improved GUIDE-Seq Analysis Pipeline for CRISPR Experiments.
2. Cambridge Semantics to Present Smart Data Lakes Findings for Improved Pharma R&D at Bio-IT World Conference and Expo 2017
3. Thermo Fisher Scientific Demonstrates Improved differentiation of Stem Cell-derived Neurons and Downstream Applications
4. Mitotech’s SkQ1 Improved Visual Acuity in Leber’s Hereditary Optic Neuropathy (LHON) Patients
5. Keystone Nano Announces Start Of Clinical Testing Of Ceramide NanoLiposome For The Improved Treatment Of Cancer
6. Technology and Telemedicine Advancements in Healthcare Boosting Improved Patient Care
7. Study Suggests Improved Method For Pinpointing If Prostate Cancer Will Return - Dr. David Samadi Investigates
8. Interbody-Fusion Outcomes May Be Improved by Use of Invibio's PEEK-OPTIMA™ HA Enhanced Polymer
9. Quadrant Plastics and MediTECH Present Material Technologies Key to Improved Performance and Reduced Production Costs in Medical Device Market at OMTEC 2016
10. New Research Reviews Tests for Improved Mesothelioma Diagnosis, According to Surviving Mesothelioma
11. Shimadzu Introduces New ATHAP Matrix Kits for Improved Characterization of Hydrophobic Peptides and Proteins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... , ... September 17, 2019 , ... Tucker, a Labrador ... only four months old, Tucker was limping and lame on his right hip and ... dysplasia and it was called “the worst case the vet had seen.” He was ...
(Date:9/17/2019)... ... September 16, 2019 , ... ... with the China Focus @ Biotech Week Boston, a forum organized by MyBioGate, ... in healthcare innovation. , After a careful process of evaluation, twelve companies out ...
(Date:9/9/2019)... ... September 09, 2019 , ... Visikol CEO Dr. Michael Johnson ... focused on how best to characterize 3D cell culture models. The inherent problem of ... too thick and opaque to image through and therefore traditional wide-field or even confocal ...
(Date:8/29/2019)... ROCHESTER, N.Y. (PRWEB) , ... August 29, 2019 ... ... within a chronic disease affecting grapevines, a feat they hope will ultimately help ... products. , Researchers including several Rochester Institute of Technology faculty and alumni sequenced ...
Breaking Biology Technology:
(Date:8/27/2019)... ... August 26, 2019 , ... Shoreline Biome , ... strain level, has hired Bill McKenzie as its CEO and Karen Woodward as its ... Shoreline Biome meet growing demand for its products and expand the company’s sales worldwide. ...
(Date:8/27/2019)... ... August 27, 2019 , ... Ambry Genetics ... improve genetic testing guidelines. In the largest cohort study of its kind, Ambry ... at-risk patients. , Clinicians use guidelines to inform decisions about which patients ...
(Date:8/25/2019)... ... 2019 , ... Sierra Instruments is pleased to announce that their redesigned website ... live. Sierra has redesigned entry to the site with both engineers and those new ... to navigate with streamlined menus and simple access to resources and information on products ...
Breaking Biology News(10 mins):